CB45776-23 - 0x0000000000006503

Males & Females of Non-Childbearing Potential

Nutshell

* Stipend may pay up to reflected amount.
Start Date: 
March 24, 2025 - 2:15pm
End Date: 
April 8, 2025 - 10:45am

Study Details

Study Number: CB45776
Group Number: 23
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 20

Study Schedule

Schedule Type: Long Term
Study Length: 7 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Friday 3/21/2025
Monday 3/24/2025

Doctor Exam Dates:

Event Day Event Date
Friday 3/21/2025
Monday 3/24/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 3/24/2025 2:15:00 PM Monday 3/31/2025 8:45:00 AM 1 Lincoln
Phone participant Tuesday 4/8/2025 10:45:00 AM 1 Lincoln